Company profile

Surgical Theater, Inc.

Surgical Theater, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on September 29, 2025 and the most recent on September 29, 2025 (SpineAR SNAP (SyncAR Spine)). Its most common review panel is Neurology (1 device).

1AI devices

2025First decision

2025Latest decision

1Specialties

Timeline

September 29, 2025 · 510(k) K252054SpineAR SNAP (SyncAR Spine) · Neurology · SBF